CISA's Pre-Ransomware Notification Initiative helped 150+ healthcare organizations avoid ransomware attacks and save considerable costs. Alerts notified of exploitable vulnerabilities, enabling pre-attack actions. Early alerts facilitated attack blocking before data theft and file encryption. CISA sent 1,200+ notifications, aiding 154 healthcare organizations against early-stage ransomware activity. Identified exfiltrated data and detailed intrusion information supported investigation and remediation. A $60 million ransomware attack on a Fortune 500 organization saw guidance from CISA bolster IT infrastructure and security controls against future attacks.

CISA Pre-Ransomware Alerts Helped 154 Healthcare Organizations Save Millions in Costs HIPAA Journal

Children's Hospital Los Angeles partners with Vital, using ERAdvisor AI tool to enhance patient-family experience with clear, predictable processes. This platform, accessed via the MyVisit portal, provides real-time updates on child's status and care changes. Vital’s ERAdvisor, employs machine learning to simplify medical notes, offering patient education, surveys, service requests, and more. Such AI tools may also improve emergency care when integrated with clinical decision-making support.

Children’s Hospital LA launches AI-driven ER patient app Healthcare IT News

OpenAI introduces memory feature to ChatGPT for personalizing responses and storing user preferences. Rolling out to limited GPT Plus customers, users can ask the bot to remember specific information. Memory contents are manageable by users, with safety steps against sensitive information storage. An incognito mode, optional memory feature usage, and feedback training options provided.

ChatGPT now has a digital memory to remember conversations Axios

2024 medtech predicted to stabilise growth above prepandemic average, focus on profitability and cash flow, continue pace in technological innovation, experience fluctuating growth across geographies, see gen AI adopters gain productivity benefits, maintain M&A deal volumes, and perceive minimal impact on industry growth by GLP-1 drugs. Insights inspired by dialogues with 200 leaders and McKinsey's decade-front medtech research.

What to expect from medtech in 2024 | McKinsey McKinsey & Company